Search - tctmd.com

Displaying 461 - 480 of 5439

Sort: Relevancy | Date

Presentation TCT 2024

Cardiovascular Devices and Global Public Health

Presenter: Bram Zuckerman

October 29, 2024

Presentation TCT 2024

Current and Future Clinical Evidence of SELUTION SLR™ DEB

Presenter: Simon Eccleshall

October 29, 2024

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

News Conference News TCT 2024

Building Real-world Clinical Evidence: Global Paradise System (GPS) Registry

Presenter: Naomi Fisher

October 28, 2024

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

Presentation TCT 2024

Novel LAAO Technology 2: Conformal Live Case

Presenter: Jens Erik Nielsen-Kudsk

October 28, 2024

Presentation TCT 2024

LAAO for Patients with NO Bleeding (CHAMPION, CATALYST)? LAAO for Patients with NO Afib (LeAAPS)? What Does the Future Hold?

Presenter: Megan Coylewright

October 28, 2024

Presentation TCT 2024

Post Procedure Medications: How Best to Prevent DRT Today and What is to Come

Presenter: Jens Erik Nielsen-Kudsk

October 28, 2024

Presentation TCT 2024

The Patient with Afib and High Bleeding Risk: Case Selection for Combined Ablation and LAAO?

Presenter: Vivek Reddy

October 28, 2024

Presentation TCT 2024

The Year in Investigational LAAO Devices: Where Are We Now? What Did We Learn?

Presenter: William Gray

October 28, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

Presentation TCT 2024

2. Innovative Approaches with OPN NC: Clinical Evidence and Real-World Applications

Presenter: Nachiket Patel

October 28, 2024

Presentation TCT 2024

Reconciling Evidence and Practice of MINOCA Diagnosis and Treatment: My Personal Recommendations

Presenter: Nadia Sutton

October 28, 2024

Presentation TCT 2024

TCT 557: Hemodynamic Physiological Assessment (FRR/iFR) Guided Revascularization in Left Main vs Defer Revascularization for Moderate Disease of Left Main: A Meta-Analysis of Up-to-Date Evidence

Presenter: yasar sattar

October 28, 2024

Presentation TCT 2024

How Cardiogenic Shock Working Group (CSWG) Registry Findings have Advanced Understanding of Pathophysiology, Prognosis and Therapeutics

Presenter: Navin Kapur

October 28, 2024

Presentation TCT 2024

The AHA Cardiogenic Shock Registry: Goals and Status Update

Presenter: Mariell Jessup

October 28, 2024

Presentation TCT 2024

Registries and Pragmatic Randomized Shock trials: how and why they should be used to study therapies for Cardiogenic Shock

Presenter: Mitchell Krucoff

October 28, 2024

Presentation TCT 2024

The Critical Care Cardiology Trial Network Shock Registry: How C3TN Findings Have Advanced Understanding of Pathophysiology, Prognosis and Therapeutics

Presenter: David Morrow

October 28, 2024

Presentation TCT 2024

How Far Can We Push Observational Data to Answer Clinical Questions: Statistical Considerations

Presenter: Robert Yeh

October 28, 2024

Presentation TCT 2024

Reconciling Evidence and Practice for a Patient with Bicuspid Aortic Valve: A Personal Perspective

Presenter: Blase Carabello

October 28, 2024

Advertisement

Cardiovascular Devices and Global Public Health

Current and Future Clinical Evidence of SELUTION SLR™ DEB

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

Building Real-world Clinical Evidence: Global Paradise System (GPS) Registry

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Novel LAAO Technology 2: Conformal Live Case

LAAO for Patients with NO Bleeding (CHAMPION, CATALYST)? LAAO for Patients with NO Afib (LeAAPS)? What Does the Future Hold?

Post Procedure Medications: How Best to Prevent DRT Today and What is to Come

The Patient with Afib and High Bleeding Risk: Case Selection for Combined Ablation and LAAO?

The Year in Investigational LAAO Devices: Where Are We Now? What Did We Learn?

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

2. Innovative Approaches with OPN NC: Clinical Evidence and Real-World Applications

Reconciling Evidence and Practice of MINOCA Diagnosis and Treatment: My Personal Recommendations

TCT 557: Hemodynamic Physiological Assessment (FRR/iFR) Guided Revascularization in Left Main vs Defer Revascularization for Moderate Disease of Left Main: A Meta-Analysis of Up-to-Date Evidence

How Cardiogenic Shock Working Group (CSWG) Registry Findings have Advanced Understanding of Pathophysiology, Prognosis and Therapeutics

The AHA Cardiogenic Shock Registry: Goals and Status Update

Registries and Pragmatic Randomized Shock trials: how and why they should be used to study therapies for Cardiogenic Shock

The Critical Care Cardiology Trial Network Shock Registry: How C3TN Findings Have Advanced Understanding of Pathophysiology, Prognosis and Therapeutics

How Far Can We Push Observational Data to Answer Clinical Questions: Statistical Considerations

Reconciling Evidence and Practice for a Patient with Bicuspid Aortic Valve: A Personal Perspective

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content